Search peptides, terms, sources/
Regulatory source · 2019

VYLEESI (bremelanotide injection), Prescribing Information / FDA approval documentation (NDA 210557)

About this source

Kind
Regulatory or official document
Population
Not applicable (regulatory record); underlying trial population per the pivotal Phase 3 trials
Primary or secondary
primary
Peer review
unknown
Retraction status
None known
Date checked
14 August 2026

Limitations

US regulatory document, usable for context/comparison only; not a UK regulatory source and must not be presented as if it establishes any UK status.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.